Results and complications of high dose rate and low dose rate brachytherapy in carcinoma of the cervix: Cerrahpaşa experience

Radiotherapy and Oncology

Volumn 67, Issue 1, 2003, Pages 97-105

  Okkan, Sait ^a   Atkovar, Gülyüz ^a   Sahinler, Ismet ^a   Dinçbaş, Fazilet Öner ^a   Koca, Ayşe ^a   Köksal, Selçuk ^a   Turkan, Sedat ^a   Uzel, Reha ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Brachytherapy; Cervical cancer; High dose rate; Low dose rate

Indexed keywords

COBALT 60; RADIUM;

ADULT; AGED; BRACHYTHERAPY; COBALT THERAPY; COLON DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RECTOVAGINAL FISTULA; RECTUM DISEASE; RECTUM HEMORRHAGE; RECTUM ULCER; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; URINARY TRACT DISEASE; UTERINE CERVIX CARCINOMA;

EID: 0038368160     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00030-6     Document Type: Conference Paper

References (42)

1. Arai T., Nakano T., Morita S., et al. High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix: A 20-year experience. Cancer. 69:1992;175-180.
2. Barillot I., Horiot J.C., Maingon P., et al. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies. Int J Radiat Oncol Biol Phys. 48:2000;189-200.
3. Bush R.S. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys. 12:1986;2047-2050.
4. Cikaric S. Radiation therapy of cervical carcinoma using either HDR or LDR afterloading: Comparison of 5-year results and complications. Strahlenther Oncol. 82:((Suppl.)):1988;119-122.
5. Clark B.G., Souhami L., Roman T.N., et al. Rectal complication in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high-dose-rate brachytherapy: a dosimetric analysis. Int J Radiat Oncol Biol Phys. 28:1994;1243-1250.
6. Clark B.G., Souhami L., Roman T.N., et al. The prediction of late complication in patients treated with high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 38:1997;989-993.
7. Cox D.R. Regression models and life tables. J R Stat Soc. 34:1972;187-220.
8. Cox J.F., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
9. Eifel P.J. High-dose-rate brachytherapy for carcinoma of the cervix: High tech or high risk? Int J Radiat Oncol Biol Phys. 24:1992;383-386.
10. Eifel P.J., Levenback C., Wharton J.T., et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 32:1995;1289-1300.
11. Fowler J.F. Dose-rate effect in normal tissues of brachytherapy. Mould R.F. Mould RF, ed. Brachytherapy. Mould RF, ed. Brachytherapy. 2:1989;26-40 Nucletron International, BV, Leersum, The Netherlands.
12. Ferrigno R., Novaes Santos P.E.R., Pellizzon A.C.A., et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys. 50:2001;1123-1135.
13. Fu K.K., Phillips T.L. High-dose rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 19:1990;791-796.
14. Fyles A.W., Pintilie M., Kirkbride P., et al. Prognostic factors in patients with cervix cancer treated by radiation therapy: Results of multiple regression analysis. Radiother Oncol. 35:1995;107-117.
15. 192Ir versus conventional radium therapy in cervix cancer: 5-year results and complications. Stralenther Oncol. 82:((Suppl.)):1988;106-113.
16. International Commission on Radiation Units: Report No.38: Dose and Volume Specifications for Reporting Intracavitary Therapy in Gynecology. Bethesda, ICRU, 1985 pp. 1-20.
17. Joslin C.A.F., O'Connell D., Howard N. The treatment of uterine carcinoma using the Cathetron III. Clinical considerations and preliminary reports on treatment results. Br J Radiol. 40:1967;895-904.
18. Joslin C.A.F., Kilara G., Khoury G. Influence of HDR fractions and dose on the 5-year results and complications of cervix cancer. Strahlenther Oncol. 82:((Suppl.)):1988;100-105.
19. Kaplan E., Meier P. Non-parametric estimations from complete observations. J Am Stat Assoc. 53:1958;457-481.
20. Kapp D.S., Fischer D., Gutierrez E., et al. Pretreatment prognostic factors in carcinoma of the uterine cervix: A multivariate analysis of the effect of age, stage, histology and blood counts on survival. Int J Radiat Oncol Biol Phys. 9:1983;445-455.
21. Kapp K.S., Stuecklschweiger G.F., Kapp D.S., et al. Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy. Radiother Oncol. 42:1997;143-153.
22. Kapp K.S., Stuecklschweiger G.F., Kapp D.S., et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and Ir-192 high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 42:1998;531-540.
23. Kuippers T. Dosimetry and complication rate in the treatment cervix carcinoma with external irradiation and brachytherapy. Strahlenther Onkol. 82:((Suppl.)):1988;127-131.
24. Lorvidhaya V., Tonusin A., Changwiwit W., et al. High-dose-rate afterloading brachytherapy in carcinoma of the cervix. An experience of 1992 patients. Int J Radiat Oncol Biol Phys. 46:2000;1185-1191.
25. Nag S., Erickson B., Thomadsen B., et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 48:2000;201-211.
26. Ogino I., Kitamura T., Okamoto N., et al. Late rectal complication following high-dose-rate intracavitary brachytherapy in cancer of the cervix. Int. J Radiat Oncol Biol Phys. 31:1995;725-734.
27. Okawa T., Sakata S., Kita-Okawa M., et al. Mould R.F., et al. Comparison of HDR versus LDR regimens for intracavitary brachytherapy of cervical cancer: Japanese experience 'International Brachytherapy'. 1992;13-17 Nucletron, Veenendaal, The Netherlands.
28. Okkan S., Atkovar G., Sahinler I., et al. A randomised study of ornidazole as a radiosensitiser in carcinoma of the cervix: long-term results. Br J Cancer. 74:((Suppl.)XXVII):1996;282-286.
29. Orton G.G., Seyedsadr M., Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys. 21:1991;1425-1434.
30. Patel F.D., Sharma S.C., Neigi P.S., et al. Low-dose-rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys. 28:1993;335-341.
31. Perez C.A., Grigsby P.W., Camel H.M., et al. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: Update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys. 31:1995;703-716.
32. Perez C.A., Grigsby P.W., Lockett M.A., et al. Radiation therapy morbidity in carcinoma of the uterine cervix: Dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys. 44:1999;855-866.
33. Petereit D.G., Pearcey R. Literature analysis of high dose rate brachtherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys. 43:1999;359-366.
34. Petereit D.G., Sarkaria J.N., Potter D.M., Schink J.C. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: Analysis of tumor recurrence - The University of Wisconsin Experience. Int J Radiat Oncol Biol Phys. 45:1999;1267-1274.
35. Peto P., Pike M.C., Armitage P., et al. Design and analysis of randomised clinical trials requiring prolonged observations of each patient: Part II. Br J Cancer. 35:1977;1-39.
36. Rotte K. Comparison of HDR afterloading and classical radium techniques for radiation therapy of cancer of the cervix uteri. Act Select Brachyther. 2:((Suppl.)):1991;42-46.
37. Sakata K., Oouchi A., Nagakura H., et al. A prospective randomised trial comparing high-dose-rate with low-dose-rate intracavitary therapy for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 51:((Suppl.)):2001;215-216.
38. Selke P., Roman T.N., Souhami L., et al. Treatment results of high dose rate brachytherapy in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 27:1993;800-809.
39. Shigematsu Y., Nishiyama K., Masaki N., et al. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose-rate: A comparative study with a low-dose rate system. Int J Radiat Oncol Biol Phys. 9:1983;351-356.
40. Teshima T., Inoue T., Ikeda H., et al. High-dose-rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Final Results of Osaka University Hospital. Cancer. 72:1993;2409-2414.
41. Uzel R., Okkan S., Töre G., Koca S. Results and complications of high-dose-rate intracavitary radiotherapy compared with conventional dose-rate in carcinoma of the cervix. Strahlenther Oncol. 82:((Suppl.)):1988;132-136.
42. Vahrson H., Römer G. 5-year results with HDR afterloading in cervix cancer: Dependence on fractionation and dose. Strahlenther Oncol. 82:((Suppl.)):1988;139-146.